#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frostbite Epidermolysis bullosa Spinal muscular atrophy Thermal burn Mitochondrial myopathy Diffuse large B-cell lymphoma Squamous cell carcinoma of head and neck Eosinophilic oesophagitis Acute myeloid leukaemia Inclusion body myositis Leukaemia Lymphatic malformation Congenital hypotransferrinaemia Hypophosphatasia Rectal cancer More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Treatment Retinoblastoma Paraneoplastic neurological syndrome – Diagnostics Sjogren’s syndrome – Diagnostics Synovial sarcoma – Basic Information Urea cycle disorder – Diagnostics Nephrotic syndrome – Basic Information Glomerulonephritis rapidly progressive – Diagnostics Retinitis pigmentosa – Diagnostics Stevens-Johnson syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pilocarpine Nitrate Azetukalner Florbetapir (18F) Tebentafusp Sodium Alginate At-1501 Hct116-A L-Tryptophan Iph6501 Guselkumab Pasireotide Ribociclib Aon-D21 Msv/As Toldc Mometasone Furoate Ph. Eur. Apalutamide Maridebart Cafraglutide Tinlarebant 12 Grass Pollen Mixture More therapies…

    Learn about Your Condition

    Peripheral artery stenosis Tourette's disorder Arthralgia Arterial tortuosity syndrome Angiosarcoma Stress Langerhans' cell histiocytosis Rhabdoid tumour Thyroid cancer Epileptic encephalopathy Insomnia Fallopian tube cancer Myelofibrosis Measles Carotid arteriosclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

    Recruiting

    3 1 1
    Investigated Drugs:
    • Antithrombin Iii Human
    • Sodium Chloride
    Austria Czechia France Lithuania Poland Romania +2

  • Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Olaparib
    Spain

  • Study on the Effects of Amikacin Sulfate and Protective Isolation in Critically Ill Neutropenic Patients with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neutropenia
    • Critical illness
    Investigated Drugs:
    • Amikacin Sulfate
    France

  • Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Afatinib
    Germany Spain

  • Study on the Effect of Durvalumab and Tremelimumab with Radioactive Glass Spheres in Patients with Non-Resectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    Germany Italy

  • Study on the Use of Human Apotransferrin for Treating Patients with Atransferrinemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Blood iron increased
    • Congenital hypotransferrinaemia
    • Hypochromic anaemia
    Investigated Drugs:
    • Human Apotransferrin
    Germany Italy Spain
Previous Page
1 … 330 331 332 333 334 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!